See how science, strategy, and innovation are transforming the GLP-1 space: #GLP1 #oralGLP1 #metabolichealth #diabetescare #obesity #obesitytreatment #pharmainnovation #futureproofingbusinesses #IeB To view or add a comment, sign in #MIMSPharmaMarketInsightUpdate, September 2025 Including: SGLT2 inhibitors should be offered first-line to people with heart failure with reduced ejection fraction A new formulation of Rybelsus (semaglutide) tablets has been released The first inhaled levodopa product, Inbrija (levodopa), has been launched
Identifying this brain area should help scientists find GLP-1 drugs that target the reward system while avoiding areas involved in appetite, Gler says
Indeed, the efficacy of melatonin has been tested against the oxygen radical diseases of newborn, giving promising results 100,101,102 (Fig
It explains why the peptide does what it does, not that it cures anything
It plays a critical role in maintaining optimal liver health and function
E., & Jemal, A
